Skip to content

PTSD: all studies

Page 190 of 210: studies 1,891 to 1,900 of 2,096, newest first. Back to the PTSD overview

Research

Perceptions of the medicinal value of hallucinogenic drugs among college students

Journal of Psychedelic Studies October 17, 2017 Jared Wildberger, Cassandra N. John, Robert M. Hallock 22 citations

This survey examined perceptions among college students about the potential medicinal benefits of hallucinogenic drugs. Current research and potential benefits include an ability to help anxiety, post-traumatic stress disorder, and addiction with hallucinogen-assisted psychotherapy. We devised and administered a survey on 124 students at two college campuses, one small private college in the...

Association of Posttraumatic Nightmares and Psychopathology in a Military Sample

Psychological Trauma: Theory, Research, Practice and Policy October 9, 2017 T. de Dassel, Lutz Wittmann, Sonja Protic et al.

Objective: Nightmares are among the most frequent and disturbing symptoms of posttraumatic stress disorder (PTSD). However, basic research questions regarding key associations between certain nightmare characteristics, especially replicativeness, and posttraumatic psychopathology need further empirical elaboration. Method: Sixty-two German soldiers (mean age 33.8 years, 17.7% females) admitted...

Separating the agony from ecstasy: R(−)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice

Neuropharmacology October 6, 2017 D. Curry, M. B. Young, A‐nga T. Tran et al. 50 citations

ABSTRACT S,R(+/–)‐3,4‐methylenedioxymethamphetamine (SR‐MDMA) is an amphetamine derivative with prosocial and putative therapeutic effects. Ongoing clinical trials are investigating it as a treatment for post‐traumatic stress disorder (PTSD) and other conditions. However, its potential for adverse effects such as hyperthermia and neurotoxicity may limit its clinical viability. We investigated...

Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.

Journal of Psychopharmacology October 2017 Paul Glue, Natalie J. Medlicott, Sarah Harland et al.

The N-methyl-D-aspartate receptor antagonist ketamine has rapid onset activity in treatment-resistant depression, post-traumatic stress disorder and obsessive compulsive disorder. Due to similarities in brain network activity in depression and anxiety disorders, we hypothesized that ketamine might also be active in other refractory anxiety disorders. We evaluated the efficacy and safety of...

The Use of Virtual Reality Facilitates Dialectical Behavior Therapy® “Observing Sounds and Visuals” Mindfulness Skills Training Exercises for a Latino Patient with Severe Burns: A Case Study

Frontiers in Psychology September 25, 2017 J. Gómez, H. Hoffman, Steven L. Bistricky et al.

Sustaining a burn injury increases an individual's risk of developing psychological problems such as generalized anxiety, negative emotions, depression, acute stress disorder, or post-traumatic stress disorder. Despite the growing use of Dialectical Behavioral Therapy® (DBT®) by clinical psychologists, to date, there are no published studies using standard DBT® or DBT® skills learning for...

Sleep Disorders Among Holocaust Survivors

The Journal of Nervous and Mental Disease August 28, 2017 Ido Lurie 4 citations

After World War II, traumatic after effects often caused persistent sleep disorders for Holocaust survivors (HSs). This is a review of studies reporting on sleep disturbances and nightmares (as primary or secondary outcomes) among HSs between 1939 and 2015, conducted in various countries and contexts (clinical settings, pension claims, community surveys, sleep laboratories). Most studies...

Jeremy Shaw's DMT

Performance Research August 18, 2017 Jennifer Fisher 1 citation

This article examines DMT by Jeremy Shaw, a Berlin-based Canadian artist whose oeuvre has investigated altered states. For this 2004 video work, Shaw administered the hallucinogen dimethyltryptamine to a group of friends and videotaped their experiences. I am interested in how Shaw curates the psychedelic session as a performance of the drug’s agency and aesthetic power. A powerful entheogen...

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.

Journal of Psychopharmacology August 1, 2017 Mark T Wagner, Michael C Mithoefer, Ann T Mithoefer et al. 163 citations

A growing body of research suggests that traumatic events lead to persisting personality change characterized by increased neuroticism. Relevantly, enduring improvements in Post-Traumatic Stress Disorder (PTSD) symptoms have been found in response to 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy. There is evidence that lasting changes in the personality feature of "openness"...

Nightmares in the general population: identifying potential causal factors

Social Psychiatry and Psychiatric Epidemiology July 15, 2017 Stephanie Rek, Bryony Sheaves, Daniel K. Freeman 54 citations

Nightmares are inherently distressing, prevent restorative sleep, and are associated with a number of psychiatric problems, but have rarely been the subject of empirical study. Negative affect, linked to stressful events, is generally considered the key trigger of nightmares; hence nightmares have most often been considered in the context of post-traumatic stress disorder (PTSD). However, many...

Mindfulness-Based Relapse Prevention for Methadone Maintenance: A Feasibility Trial.

The Journal of Alternative and Complementary Medicine July 1, 2017 Sarah Bowen, Vanessa C Somohano, Rachel E Rutkie et al.

As rates of opiate misuse rise in the United States, so do significant associated health and financial consequences to afflicted individuals, their families, and society at large. Methadone maintenance therapy (MMT) is one evidence-based approach to treating opiate addiction, yet supplemental psychosocial treatment to support this approach is lacking. Mindfulness-based relapse prevention (MBRP)...

DOI: 10.1089/acm.2016.0417 (opens in new tab) Full text (opens in new tab) Meditation Methadone maintenance therapy Mindfulness-based relapse prevention Substance use